Microvesicle Particle: Clinical Trials

2 trials for Microvesicle Particle, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 withdrawn. 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Withdrawn 1
Phase 11Recruiting 1

Follow Microvesicle Particle: new trials by email Literature Review of Microvesicle Particle trials Research Report on Microvesicle Particle

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
4% Imipramine Cream, Base Cream - Photosensitivity, Microvesicle Particle
Phase 1RecruitingWright State University402022-06-062025-01-27
Photodynamic Therapy and Microvesicles
Photodynamic Therapy, 4% Imipramine, Base Cream - Photodynamic Therapy, Microvesicle Particle
Early Phase 1WithdrawnWright State University2021-03-292022-09-13

Narrower conditions

Photosensitivity Disorders (1)

Broader conditions

Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Imipramine (1)  ·  Photochemotherapy (1)

Sponsors

Wright State University (2)

Countries

United States (2)

Top investigators

Jeffrey B Travers, MD, PhD (2)